JPMORGAN CHASE & CO - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,564
-97.5%
8,408
-94.2%
0.00%
Q2 2023$101,213
-51.1%
143,768
-37.7%
0.00%
Q1 2023$207,000
+155539.1%
230,667
+105.0%
0.00%
Q4 2022$133
-100.0%
112,531
-1.6%
0.00%
Q3 2022$862,000
+19.4%
114,411
-0.2%
0.00%
Q2 2022$722,000
-22.4%
114,658
+2.3%
0.00%
Q1 2022$931,000
+55.7%
112,121
-2.6%
0.00%
Q4 2021$598,000
-22.8%
115,105
-0.8%
0.00%
Q3 2021$775,000
-34.1%
116,078
-15.9%
0.00%
Q2 2021$1,176,000
+3.7%
137,980
+7.8%
0.00%
Q1 2021$1,134,000
-54.6%
127,990
-37.1%
0.00%
Q4 2020$2,500,000
+50.5%
203,477
+1.4%
0.00%
Q3 2020$1,661,000
-44.3%
200,676
-35.4%
0.00%
-100.0%
Q2 2020$2,980,000
+48.9%
310,451
+5.5%
0.00%
Q1 2020$2,001,000
-59.6%
294,376
-11.4%
0.00%
-100.0%
Q4 2019$4,948,000
+56.9%
332,094
+7.9%
0.00%0.0%
Q3 2019$3,154,000
+827.6%
307,685
+868.1%
0.00%
Q2 2019$340,000
-50.6%
31,781
-35.4%
0.00%
Q1 2019$688,000
-25.8%
49,193
-36.3%
0.00%
Q3 2018$927,000
+100.6%
77,247
+103.8%
0.00%
Q2 2018$462,000
+156.7%
37,904
+193.5%
0.00%
Q4 2017$180,000
+42.9%
12,915
+10.3%
0.00%
Q3 2017$126,000
+447.8%
11,705
+295.8%
0.00%
Q2 2017$23,000
-28.1%
2,957
+7.3%
0.00%
Q1 2017$32,000
-27.3%
2,757
-27.0%
0.00%
Q4 2016$44,0003,7750.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders